Crystalline forms of 11 beta- (4-acetylphenyl)-20,20,21,21,21-pentafl uor-17hydroxy19-nor-17alpha-pregna-4,9-dien-3-one

Details for Australian Patent Application No. 2007256432 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Winter, Gabriele; Cleve, Arwed; Kramer, Edda; Amoulong, Evelin; Ginko, Thomas; Beckmann, Wolfgang

Agent Davies Collison Cave

Pub. Number AU-A-2007256432

PCT Pub. Number WO2007/140917

Priority 60/810,127 02.06.06 US; 06090095.8 02.06.06 EP

Filing date 31 May 2007

Wipo publication date 13 December 2007

International Classifications

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2007/140917 Priority application(s): WO2007/140917

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007256433-Device for absorption of noise

2007256431-Container with magnetic sealing means